Newly developed autoimmune cholangitis without relapse of autoimmune pancreatitis after discontinuing prednisolone

World Journal of Gastroenterology

Volumn 18, Issue 41, 2012, Pages 5990-5993

  Kim, Ji Hun ^a   Chang, Jae Hyuck ^a   Nam, Sung Min ^a   Lee, Mi Jeong ^a   Maeng, Il Ho ^a   Park, Jin Young ^a   Im, Yun Sun ^a   Kim, Tae Ho ^a   Kim, Chang Whan ^a   Han, Sok Won ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Autoimmune disease; Cholangitis; Pancreatitis; Prednisolone

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; PREDNISOLONE; STEROID;

ADULT; ARTICLE; ASPIRATION CYTOLOGY; AUTOIMMUNE PANCREATITIS; BILE DUCT DILATATION; CASE REPORT; CHOLANGITIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; JAUNDICE; LOW DRUG DOSE; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; PHYSICAL EXAMINATION; STENT; WEIGHT REDUCTION;

EID: 84873917190     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i41.5990     Document Type: Article

References (13)

1. Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med 2006; 355: 2670-2676
2. Sah RP, Chari ST, Pannala R, Sugumar A, Clain JE, Levy MJ, Pearson RK, Smyrk TC, Petersen BT, Topazian MD, Takahashi N, Farnell MB, Vege SS. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010; 139: 140-148; quiz 140-148
3. Chari ST, Murray JA. Autoimmune pancreatitis, Part II: the relapse. Gastroenterology 2008; 134: 625-628
4. Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, Kim MH, Klöppel G, Lerch MM, Löhr M, Notohara K, Okazaki K, Schneider A, Zhang L. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011; 40: 352-358
5. Kamisawa T, Funata N, Hayashi Y. Lymphoplasmacytic sclerosing pancreatitis is a pancreatic lesion of IgG4-related systemic disease. Am J Surg Pathol 2004; 28: 1114
6. Moon SH, Kim MH, Park DH, Hwang CY, Park SJ, Lee SS, Seo DW, Lee SK. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 2008; 57: 1704-1712
7. Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol 2006; 41: 613-625
8. Park do H, Kim MH. Intrapancreatic common bile duct involvement of autoimmune pancreatitis: is it really IgG4-associated cholangitis? Gastroenterology 2008; 135: 324-35; author reply 325
9. Kamisawa T, Shimosegawa T, Okazaki K, Nishino T, Watanabe H, Kanno A, Okumura F, Nishikawa T, Kobayashi K, Ichiya T, Takatori H, Yamakita K, Kubota K, Hamano H, Okamura K, Hirano K, Ito T, Ko SB, Omata M. Standard steroid treatment for autoimmune pancreatitis. Gut 2009; 58: 1504-1507
10. Kamisawa T, Takuma K, Hara S, Tabata T, Kuruma S, Inaba Y, Gopalakrishna R, Egawa N, Itokawa F, Itoi T. Management strategies for autoimmune pancreatitis. Expert Opin Pharmacother 2011; 12: 2149-2159
11. Sandanayake NS, Church NI, Chapman MH, Johnson GJ, Dhar DK, Amin Z, Deheragoda MG, Novelli M, Winstanley A, Rodriguez-Justo M, Hatfield AR, Pereira SP, Webster GJ. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2009; 7: 1089-1096
12. Moon SH, Kim MH, Park do H. Treatment and relapse of autoimmune pancreatitis. Gut Liver 2008; 2: 1-7
13. Park SJ, Kim MH, Moon SH, Han JH, Park do H, Lee SS, Seo DW, Lee SK. [Clinical characteristics, recurrence features, and treatment outcomes of 55 patients with autoimmune pancreatitis]. Korean J Gastroenterol 2008; 52: 230-246